Eskag Sanjeevani Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 03-07-2024
- Paid Up Capital ₹ 2.96 M
as on 03-07-2024
- Company Age 16 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 155.72 Cr
as on 03-07-2024
- Satisfied Charges ₹ 50.84 Cr
as on 03-07-2024
- Revenue 42.11%
(FY 2022)
- Profit 216.79%
(FY 2022)
- Ebitda 79.58%
(FY 2022)
- Net Worth 75.30%
(FY 2022)
- Total Assets 33.87%
(FY 2022)
About Eskag Sanjeevani
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 2.96 M.
The company currently has active open charges totaling ₹155.72 Cr. The company has closed loans amounting to ₹50.84 Cr, as per Ministry of Corporate Affairs (MCA) records.
Suchi Agarwal and Anil Agarwal serve as directors at the Company.
- CIN/LLPIN
U85191WB2008PTC124543
- Company No.
124543
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 Mar 2008
- Date of AGM
20 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
North 24 Parganas, West Bengal, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Eskag Sanjeevani?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Suchi Agarwal  | Director | 27-Mar-2008 | Current |
| Anil Agarwal | Director | 27-Mar-2008 | Current |
Financial Performance and Corporate Structure Insights of Eskag Sanjeevani.
Eskag Sanjeevani Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 42.11% increase. The company also saw a substantial improvement in profitability, with a 216.79% increase in profit. The company's net worth Soared by an impressive increase of 75.3%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Eskag Sanjeevani?
In 2021, Eskag Sanjeevani had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
West Bengal Chemical Industries Ltd.Active 36 years 7 monthsSuchi Agarwal and Anil Agarwal are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Limited Creation Date: 15 Sep 2023 | ₹20.00 Cr | Open |
Others Creation Date: 16 Feb 2023 | ₹13.68 Cr | Open |
Yes Bank Limited Creation Date: 27 Nov 2020 | ₹1.19 Cr | Open |
How Many Employees Work at Eskag Sanjeevani?
Eskag Sanjeevani has a workforce of 1910 employees as of Apr 03, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Eskag Sanjeevani, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Eskag Sanjeevani's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
